India to Russia: Ambroxol Export Trade Route
India has recorded 34 verified shipments of Ambroxol exported to Russia, representing a combined trade value of $500.3K USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $14.7K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 43% of total export value with 7 shipments worth $214.7K USD. On the buying side, AO "RANBAXY" is the largest importer in Russia with $124.9K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, INTIGREAT CONSULTING SERVICES LLP, SYMBIO GENERRICS INDIA PRIVATE LIMITED — together control 94% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Russia Ambroxol corridor is one of India's established pharmaceutical export routes, with 34 shipments documented worth a combined $500.3K USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 43% of all export value, reflecting the consolidated nature of India's ambroxol manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $14.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 8.8%, placing it at rank #8 among India's top ambroxol export destinations globally.
On the import side, key buyers of Indian ambroxol in Russia include AO "RANBAXY", OOO S PHARMA, AO RANBAXY and 6 others. AO "RANBAXY" is the single largest importer with 4 shipments valued at $124.9K USD.
